G. Jego et al., Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells, BLOOD, 94(2), 1999, pp. 701-712
Circulating plasma cells in 10 cases of reactive plasmacytosis had a shared
phenotype with early plasma cell (CD19(+) CD38(+) CD138(+) CD40(+) CD45(+)
CD11a(+) CD49e(-) CD56(-)). In most cases, a minor subpopulation of CD28() plasma cells was also detected. Reactive plasma cells were highly prolife
rative, suggesting the presence of circulating progenitors (plasma-blasts).
After CD138(+) plasma cell removal, highly proliferative CD138(-) plasmabl
asts differentiated into CD138(+) plasma cells within a few days. This diff
erentiation, which was associated with increased CD38 and decreased HLA-DR
expression, was further confirmed by a large increase in intracellular Ig c
ontent (associated with Ig secretion) and was concomitant with extensive se
cretion of interleukin-6 (IL-6). The addition of neutralizing anti-IL-6 and
anti-CD126 (IL-6 receptor) monoclonal antibodies totally prevented Ig secr
etion and cell differentiation by inducing apoptosis of plasmablasts, which
indicates that IL-6 is an essential survival factor for plasmablasts. This
report provides the first characterization of normal plasmablasts and show
s that their phenotype is not exactly that of multiple myeloma cells, (C) 1
999 by The American Society of Hematology.